Hints and tips:
...formally put itself up for sale – voted against three planned new investments, undermining the board’s efforts to rebuild the company after the sale of its pivotal multiple sclerosis drug Tysabri this spring...
...The decision to drop the hostile bid brings to an end a bitter takeover battle for Elan launched in the spring....
International Edition